Trials / Completed
CompletedNCT05825326
Epidemiological and Clinical-pathological Factors of Philadelphia-negative Myeloproliferative Neoplasms in Ecuador
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Sociedad de Lucha Contra el Cáncer del Ecuador · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to evaluate the epidemiological and clinical-pathological features of Philadelphia-negative myeloproliferative neoplasms through data from medical records
Detailed description
The investigators are proposing a study that provides descriptive understanding of patients with Philadelphia-negative myeloproliferative neoplasms in Ecuador. The primary objective of this pilot study is to lay the foundations for the development of a multicenter registry of Philadelphia-negative myeloproliferative neoplasms, which will provide high-quality real data and serve as a basis for the application to future projects and elaboration of public policies in the medium and long term.
Conditions
- Myeloproliferative Neoplasm
- Myeloproliferative Syndrome
- Myeloproliferative Neoplasm, Unclassifiable
- Myeloproliferative Disorders
- Myeloproliferative Disease, Not Classified
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2023-04-24
- Last updated
- 2023-04-27
Locations
1 site across 1 country: Ecuador
Source: ClinicalTrials.gov record NCT05825326. Inclusion in this directory is not an endorsement.